RRC
46
-2
MCD
46
4
AKAM
48
-11
DHR
50
4
FTI
76
2
LLY
73
-3
EXPE
66
2
GILD
50
13
PRU
50
2
CFG
34
4
JPM
60
-2
T
45
3
XYL
43
-4
AMAT
60
-4
AEP
56
-2
ZTS
49
20
CINF
48
-2
INTC
47
6
NWL
32
4
GM
61
-4
RRC
46
-2
MCD
46
4
AKAM
48
-11
DHR
50
4
FTI
76
2
LLY
73
-3
EXPE
66
2
GILD
50
13
PRU
50
2
CFG
34
4
JPM
60
-2
T
45
3
XYL
43
-4
AMAT
60
-4
AEP
56
-2
ZTS
49
20
CINF
48
-2
INTC
47
6
NWL
32
4
GM
61
-4
Financhill
Back

Vinci Partners Investments Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
54

VINP
Vinci Partners Investments

Last Price:
10.90
Seasonality Move:
7.43%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Buy
54
Vinci Partners Investments (VINP) is a Buy

Is Vinci Partners Investments a Buy, Sell or Hold?

  • The current Vinci Partners Investments [VINP] share price is $10.93. The Score for VINP is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • VINP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VINP Stock Price Chart

What is Vinci Partners Investments's stock price today?

  • The Vinci Partners Investments share price today is $10.93
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VINP is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

VINP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 55.96 Buy
Chaikin Money Flow: 104551 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.59 - 10.89) Buy
Bollinger Bands (100): (10.54 - 11.16) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

VINP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.67 Buy
20-day SMA: 10.71 Buy
50-day SMA: 10.71 Buy
200-day SMA: 10.65 Buy
8-day EMA: 10.75 Buy
20-day EMA: 10.73 Buy
50-day EMA: 10.77 Buy
200-day EMA: 10.58 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Vinci Partners Investments Earnings Growth & VINP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, an increase next quarter of $0.09 per share, a decrease this year of $0.14 per share, and an increase next year of $0.22 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Vinci Partners Investments Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):